e-Drug3D 346 |
MEFENAMIC ACID
|
cas 61-68-7 |
CLASS MUSCULO-SKELETAL SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 2 HOUR Solubility 0.004 PERCENT IN WATER |
Target TARGET PROSTAGLANDIN G/H SYNTHASE 1 PROSTAGLANDIN G/H SYNTHASE 2 PDB Ligand code = ID8 (link to the list of PDB complexes) Download experimental 3D coordinates of ID8 with added hydrogens |
DrugCentral Prostaglandin G,H synthase 2 UNIPROT P35354 PTGS2 Prostaglandin G,H synthase 1 UNIPROT P23219 PTGS1 |
Download SDF file | 2-[(2,3-dimethylphenyl)amino]benzoic acid Formula: Calculated chemical properties: MW 240.27 NB_atoms 18 XLogP 2.41 PSA 42.769 NB_HD 1 NB_HA 3 fsp3 0.13 Lipinski(0=no;1=yes) 1 |
FDA NDA 015034 (label) INN (MEFENAMIC ACID) PONSTEL (AVION PHARMS) APPROVAL= AP YEAR= 1967 NDA 090562 (pdf not found) INN (MEFENAMIC ACID) MEFENAMIC ACID (MICRO LABS) APPROVAL= AP YEAR= 2010 NDA 091322 (pdf not found) INN (MEFENAMIC ACID) MEFENAMIC ACID (LUPIN LTD) APPROVAL= AP YEAR= 2011 NDA 090359 (pdf not found) INN (MEFENAMIC ACID) MEFENAMIC ACID (MPP PHARMA) APPROVAL= AP YEAR= 2013 DISCONTINUED NDA 091608 (pdf not found) INN (MEFENAMIC ACID) MEFENAMIC ACID (AJENAT PHARMS) APPROVAL= AP YEAR= 2014 NDA 209209 (pdf not found) INN (MEFENAMIC ACID) MEFENAMIC ACID (CHARTWELL RX) APPROVAL= AP YEAR= 2020 DISCONTINUED |
Other links: |